E-poster No. / 壁報編號
C16
Title / 題目
HER2/CEP17 ratio predicts survival outcome in advanced HER2-positive breast cancer treated with pertuzumab, trastuzumab, and docetaxel
First Author / 第一作者
Dae-Won Lee
Institution / 單位
Seoul National University Hospital
Audio / 音訊檔
Author Group / 作者群
Seoul National University Hospital
Author Group Institution/ 作者群單位
Seoul National University Hospital
Category / 主題分類
Clinical Research
Keyword / 關鍵字
HER2 positive breast cancer, HER2/CEP17 ratio, HER2 ISH, dual HER2 blockade
